Biosynthesis and purification of a hydrophobic peptide from transmembrane domains of G‐protein‐coupled CB2 receptor
- 16 March 2005
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 65 (4) , 450-458
- https://doi.org/10.1111/j.1399-3011.2005.00239.x
Abstract
A major challenge for the structural study of the seven‐transmembrane G‐protein‐coupled receptors is to obtain a sufficient amount of purified protein at the milligram level, which is required for either nuclear magnetic resonance (NMR) spectroscopy or X‐ray crystallography. In order to develop a high‐yield and cost‐effective method, and also to obtain preliminary structural information for the computer modeling of the three‐dimensional receptor structural model, a highly hydrophobic peptide from human cannabinoid subtype 2 receptor CB265−101, was chosen to develop high‐yield membrane protein expression and purification methods. The peptide included the second transmembrane helix with the associated loop regions of the CB2 receptor. It was over‐expressed in Escherichia coli, with a modified TrpΔ LE1413 (TrpLE) leading fusion sequence and a nine‐histidine tag, and was then separated and purified from the tag in a preparative scale. An experimental protocol for the chemical cleavage of membrane protein fragment was developed using cyanogen bromide to remove the TrpLE tag from the hydrophobic fusion protein. In addition, protein uniformly labeled with isotopic 15N was obtained by expression in 15N‐enriched minimum media. The developed and optimized preparation scheme of expression, cleavage, and purification provided a sufficient amount of peptide for NMR structure analysis and other biophysical studies that will be reported elsewhere. The process of fusion protein cleavage following purification was monitored by high‐performance liquid chromatography (HPLC) and mass spectrometry (MS), and the final sample was validated by MS and circular dichroism experiments.Keywords
This publication has 55 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Structure of bacteriorhodopsin at 1.55 Å resolutionJournal of Molecular Biology, 1999
- The structure of bacteriorhodopsin at 3.0 Å resolution based on electron crystallography: implication of the charge distribution 1 1Edited by R. HuberJournal of Molecular Biology, 1999
- Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune SystemToxicology and Applied Pharmacology, 1997
- Molecular Aspects of Cannabinoid ReceptorsCritical Reviews™ in Neurobiology, 1997
- AM630, a competitive cannabinoid receptor antagonistLife Sciences, 1995
- Formation of a native‐like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitorProtein Science, 1994
- Three‐dimensional structure of (1–36)bacterioopsin in methanol—chloroform mixture and SDS micelles determined by 2D 1H‐NMR spectroscopyFEBS Letters, 1992
- Spatial structure of (34–65)bacterioopsin polypeptide in SDS micelles determined from nuclear magnetic resonance dataJournal of Biomolecular NMR, 1992
- Bacteriorhodopsin: A trans-membrane pump containing α-helixJournal of Molecular Biology, 1975